Uliana Denisovna Dyachkova

Uliana Denisovna Dyachkova

Auto-generated profile, based on publicly available information

Uliana Denisovna Dyachkova

Lomonosov Moscow State University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2023 in Experimental Gerontology
Verified
Journal Article
Open access
ASAnna Grigorevna Sorokina
Anna Grigorevna Sorokina
IOIana Orlova
Iana Orlova
OGOlga Grigorieva
Olga Grigorieva
ENEkaterina Novoseletskaya
Ekaterina Novoseletskaya
NBNataliya Basalova
Nataliya Basalova
AEAnastasia Efimenko
Anastasia Efimenko
The aim of the study was to investigate the relationship between established clinical systemic biomarkers of ageing and the development of age-associated diseases and senescent cell biomarkers at tissue and cellular levels. Thirty-eight patients (mean age 70 ± 4.9 years) who were assessed for traditional risk factors for cardiovascular diseases were included. From all patients we obtained biomaterials (peripheral blood, skin, subcutaneous fatty tissue) and isolated different cell types (peripheral blood mononuclear cells (PBMC), fibroblasts (FB) and mesenchymal stem/stromal cells (MSC)). Isolated cells were analyzed using several senescent cells biomarkers such as telomere length and telomerase activity, proliferation rate, cell cycle inhibitor expression (p16 and p21), b-galactosidase activity, gH2AX expression. CD34+ cell content in peripheral blood was determined by flow cytometry. Systemic senescent cell-associated factors (insulin-like growth factor 1 (IGF-1), fibroblast growth factor 21 (FGF-21), osteoprogerin, ferritin, soluble vascular cell adhesion molecule (VCAM-1), intercellular adhesion molecule 1 (ICAM-1)) in peripheral blood as well as senescence-associated secretory phenotype (SASP) components in MSC and FB secretome were evaluated by ELISA. Skin and adipose tissue biopsy samples were analyzed histologically to assess senescent cell markers. A strong significant association of tissue p16 expression with age (r = 0.600, p < 0.001), pulse wave velocity (PWV) (r = 0.394, p = 0.015), vascular cell adhesion molecule (VCAM-1) content (r = 0.312, p = 0.006) in the systemic blood stream and p16 mRNA level in the blood mononuclear cells (MNCs) (r = 0.380, p = 0.046) were confirmed by correlation analysis. Statistically significant correlations were found with indicators of FBs and MSCs proliferation in culture and acquisition of SASP by the cells. Thus, p16 expression in tissues correlated significantly with interleukin-6 (IL-6) (r = 0.485, p < 0.05) and monocyte chemoattractant protein type 1 (MCP-1) (r = 0.372, p < 0.05) secretion by isolated cells. The results of regression analysis confirmed that, regardless of age, the expression of p16 was associated with the proliferation of isolated cells and IL-6 within SASP. Based on these findings, two models have been proposed to predict the level of p16 expression in tissues from the levels of other markers of senescent cell accumulation determined by non-invasive methods and available in clinical practice.

22 August 2024 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
OGOlga Grigorieva
Olga Grigorieva
NBNataliya Basalova
Nataliya Basalova
UDUliana Dyachkova
Uliana Dyachkova
ENEkaterina Novoseletskaya
Ekaterina Novoseletskaya
MVMaksim Vigovskiy
Maksim Vigovskiy
AEAnastasia Efimenko
Anastasia Efimenko

8 January 2022 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ASA. G. Sorokina
A. G. Sorokina
IOIana Orlova
Iana Orlova
OGOlga Grigorieva
Olga Grigorieva
ENEkaterina Novoseletskaya
Ekaterina Novoseletskaya
NBNataliya Basalova
Nataliya Basalova
AEAnastasia Efimenko
Anastasia Efimenko
With aging, tissue homeostasis and their effective recovery after damage is violated. It has been shown that this may be due to the excessive accumulation of senescent (SC) cells in various tissues, which leads to the activation of chronic sterile inflammation, tissue dysfunction and, as a result, to the development of age-related diseases. To assess the contribution of SC cells to human body aging and pathogenesis of such diseases, relevant biomarkers are studied. For successful translation into clinical practice of approaches aimed at regulating the SC cell content in various tissues, it is necessary to study the relationship between the established clinical biomarkers of aging and age-related diseases, systemic aging parameters, and SC biomarkers at the tissue and cellular levels.Aim. To develop and describe action algorithms for creating a biobank of samples obtained from patients aged >65 years in order to study biomarkers of SC cell accumulation.Material and methods. To collect samples, an interaction system was built between several research, clinical and infrastructure departments of a multidisciplinary medical center. At the stage of preanalytical training, regulatory legal acts were developed, including informed consent for patients, as well as protocols for each stage of the study.Results. A roadmap was formed with action algorithms for all participants in the study, as well as with a convenient and accessible system of annotations and storage of biological samples. To date, the collection includes biological samples of 7 different types (peripheral blood serum, formalin-fixed tissue samples and formalin fixed paraffin embedded tissue specimens, samples of different cells isolated from peripheral blood, skin and adipose tissue, samples of deoxyribonucleic and ribonucleic acids, cell secretome conditioned media) obtained from 82 patients. We accumulated relevant anamnestic, clinical and laboratory data, as well as the results of experimental studies to assess the SC cell biomarkers. Using the collection, the relationship between clinical, tissue and cellular biomarkers of SC cell accumulation was studied.Conclusion. The creation of a collection of biological samples at the molecular, cellular, tissue and organism levels from one patient provides great opportunities for research in the field of personalized medicine and the study of age-related disease pathogenesis.

25 July 2025 in Drug development & registration
Verified
Journal Article
Open access
PDF file
UDU. D. Dyachkova
U. D. Dyachkova
NBNataliya Basalova
Nataliya Basalova
MVMaksim Vigovskiy
Maksim Vigovskiy
AEAnastasia Efimenko
Anastasia Efimenko
OGOlga Grigorieva
Olga Grigorieva
Introduction. The vesicular fraction of human mesenchymal stem/stromal cells (EV MSCs) secretome can be considered as a pharmaceutical substance for the biological drug development to treat fibrotic diseases. Biological drugs quality control requires standard tests using simple validable methods. Additionally, it is necessary to assess specific activity using relevant models based on specific cellular targets and mechanisms of action.Aim. Development of cell models for specific activity assessment of the biological drug from human EV MSCs for the fibrotic diseases treatment.Materials and methods. We proposed two in vitro models to evaluate specific activity: the first one is primary human dermal fibroblast (HDF) cell lines induced differentiation model and the second one is polarization of macrophages derived from human peripheral blood monocytes.Results and discussion. Transforming growth factor (TGFβ-1) treatment of HDF increased the level of the main myofibroblasts marker – alpha-smooth muscle actin (αSMA) within 96 hours. The simultaneous action of TGFβ-1 and EV-MSCs significantly decreased αSMA level compared to TGFβ-1-stimulated fibroblasts. Macrophages polarization towards M1-type with LPS/IFNγ combination resulted in increased IL-6, IL-12p35, TNFα genes expression after both 4 and 24 hours. The EV-MSCs addition to M1-type decreased the gene expression of proinflammatory cytokines IL-6, IL-12p35, TNFα in 24 hours.Conclusion. We developed two in vitro models to assess specific activity of antifibrotic drug based on human EV-MSCs. In the first model value of specific activity is at least 2.5-fold decrease of αSMA level in TGFβ-1-stimulated HDF, comparing to non-treated control. In the second model the value is at least two-fold decrease in the level of IL-12p35, IL-6, TNFα expression in M1 macrophages, compared to non-treated M1 macrophages.

1 December 2025 in Moscow University Biological Sciences Bulletin
Verified
Journal Article
Closed access
PDF file
OGOlga Grigorieva
Olga Grigorieva
NBNataliya Basalova
Nataliya Basalova
MVMaksim Vigovskiy
Maksim Vigovskiy
UDU. D. Dyachkova
U. D. Dyachkova
DBDmitry Bagrov
Dmitry Bagrov
AEAnastasia Efimenko
Anastasia Efimenko
Intercellular communication is a critical component of maintaining tissue homeostasis. One of the communication methods is the transfer of a wide range of